Galsulfase (Naglazyme)
The objective of this review is to evaluate the beneficial and harmful effects of galsulfase 1 mg/kg IV infusion once weekly as long-term enzyme replacement therapy (ERT) in patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome) (MPS VI)
Corporate Author: | |
---|---|
Format: | eBook |
Language: | English |
Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2016, 2016 Nov
|
Series: | Common drug review
|
Subjects: | |
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Summary: | The objective of this review is to evaluate the beneficial and harmful effects of galsulfase 1 mg/kg IV infusion once weekly as long-term enzyme replacement therapy (ERT) in patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome) (MPS VI) |
---|---|
Physical Description: | 1 online resource illustration |